All Articles
Umbilical Cord Blood in Rare Disease Treatment
How cord blood stem cells treat rare genetic disorders, improve survival and neurological outcomes, and why banking at birth offers timely access to transplants.
Mesenchymal Stem Cells for Crohn's Fistulas: Research Update
MSC therapies for Crohn's fistulas show ~58% remission at 6 months; adipose and cord-derived cells are promising and generally well tolerated.
Clinical Trials for Stem Cell Disc Repair
Examines clinical trials of stem cell treatments for degenerative disc disease, reporting structural regeneration, pain outcomes, safety, and emerging delivery and cell-free therapies.
Advances in Muscle Regeneration Using Cord Blood
Umbilical cord blood and exosomes reduce inflammation, activate satellite cells, and help restore muscle mass and function after aging or injury.
Future of Cord Blood in Regenerative Therapy
A concise overview of cord blood’s role in regenerative medicine, current uses, advances in cell expansion and gene editing, and challenges for banking and access.
Regulatory Standards for Data Security in Stem Cell Banking
Compare HIPAA, FDA and GDPR rules for protecting genetic and health data in stem cell banks, covering encryption, breach reporting and data retention conflicts.
Umbilical Cord Stem Cells for Knee Osteoarthritis
How umbilical cord MSCs can reduce knee osteoarthritis pain, support cartilage repair, and show favorable safety when used alone or with HA/surgery.
Health Indicators for Autoimmune Stem Cell Therapy
Patient age, disease stage, immune biomarkers, and stem cell source and storage strongly affect autoimmune stem cell therapy outcomes.
Cord Blood Collection: Safety Protocols Explained
Clear overview of cord blood collection safety: maternal screening, sterile kits, transport, cryopreservation, and accreditation for long-term viability.